Circulating Tumor DNA in Surgical Lung Cancer Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03081741|
Recruitment Status : Recruiting
First Posted : March 16, 2017
Last Update Posted : May 23, 2017
|Condition or disease|
Studies have shown the feasibility of detecting mutation status by blood circulating tumor DNA (ctDNA) in lung cancer patients.
The investigators plan to test the blood ctDNA in surveillance of surgical lung cancer patients. And evaluate the correlation between ctDNA level with tumor relapse or metastasis.
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||A Prospective Study of Circulating Tumor DNA Detection in Surveillance for Lung Cancer Patients|
|Actual Study Start Date :||May 3, 2017|
|Estimated Primary Completion Date :||December 1, 2017|
|Estimated Study Completion Date :||March 18, 2020|
- Effect of surgery on ctDNA of lung cancer patients [ Time Frame: before surgery and 7days after surgery ]Changes of blood ctDNA of lung cancer patients before and after surgery.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03081741
|Contact: Chaoyu Liu, PhDemail@example.com|
|Contact: Xiaohua Li, PhDfirstname.lastname@example.org|
|Shenzhen Second People's Hospital||Recruiting|
|Shenzhen, Guangdong, China, 518035|
|Contact: Geng Tian, MD email@example.com|
|Contact: Chaoyu Liu, PhD firstname.lastname@example.org|
|Principal Investigator: Shaolin Lin|
|Principal Investigator: Youhui Qian|
|Principal Investigator: Da Wu|
|Study Chair:||Geng Tian, MD||Shenzhen Second People's Hospital|